Dr Reddy's Laboratories on Thursday said it has launched in the US generic Bupropion hydrochloride extended-release tablets indicated as an aid to smoking cessation treatment.
The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration (USFDA), the drug firm said in a filing to BSE.
The product is a generic version of GSK group of companies' Zyban extended-release tablets, it added.
According to IQVIA Health, the Zyban brand and generic had US sales of around USD 5.4 million MAT for the 12 months ended June 2019, the company said.
Dr Reddy's tablets are available as 150 mg dosage strength in bottle count sizes of 60, it added.
Shares of Dr Reddy's Laboratories were trading at Rs 2,667.05 per scrip on BSE, up 2.51 per cent from the previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app